VICP 與 CICP 補償申請：先核對適用制度，法院呈請與行政申請不可混用 | VICP and CICP compensation: distinguish c... - Printable Version +- INL3 Community | 中英生活社群 (https://inl3.com) +-- Forum: 美國 | United States (https://inl3.com/forumdisplay.php?fid=1) +--- Forum: 保險 | Insurance (https://inl3.com/forumdisplay.php?fid=5) +--- Thread: VICP 與 CICP 補償申請：先核對適用制度，法院呈請與行政申請不可混用 | VICP and CICP compensation: distinguish c... (/showthread.php?tid=2184)

VICP 與 CICP 補償申請：先核對適用制度，法院呈請與行政申請不可混用 | VICP and CICP compensation: distinguish c... - INL3 保險新聞台 - 10-05-2026 VICP 與 CICP 補償申請：先核對適用制度，法院呈請與行政申請不可混用 HRSA 的 VICP 與 CICP 是兩個不同的傷害補償制度。VICP 適用於符合規定的疫苗；CICP 涵蓋依法指定的公共衞生應對措施。HRSA 現行指引將 COVID-19 疫苗及相關措施的申請導向 CICP，不能只按產品名稱或曾接種疫苗就判斷一定合資格。 VICP 須向美國聯邦索賠法院提交呈請，並把副本交 HHS；單在 HRSA 上載副本不等於已向法院立案。CICP 走行政程序，一般須在使用措施後一年內提出，並依規定提交使用證明及醫療紀錄；它不接受以電郵或傳真遞交申請或意向書。時限、例外及證據要求應即向官方核對：VICP 800-338-2382、CICP 855-266-2427。兩者均須正式審查，不能把申請紀錄當成傷害成因證明。 官方來源： https://www.hrsa.gov/cicp/cicp-vicp https://www.hrsa.gov/vaccine-compensation/how-to-file https://www.hrsa.gov/cicp 查閱日期：2026-10-04（美國太平洋時間）。本篇為參考指南，並非即時新聞；原文首次刊登日期未能確認。 圖片：2006 年試管資料照，並非疫苗、受傷證據、患者樣本或 HRSA 實驗室。 Jeffrey M. Vinocur · CC BY 2.5 · 2006-04-21. Test tubes, 2006; not vaccines, injury evidence, patient samples or an HRSA laboratory. Licence: https://creativecommons.org/licenses/by/2.5/ Photo source: https://commons.wikimedia.org/wiki/File:Test_tubes.jpg Display-size derivative; no INL3 content edits. English VICP and CICP compensation: distinguish court petitions from administrative requests HRSA operates two different injury-compensation systems. VICP concerns qualifying vaccines; CICP covers countermeasures designated under the relevant law. Current HRSA guidance directs COVID-19 vaccine and related countermeasure claims to CICP. A product name or vaccination history alone does not establish eligibility. VICP requires a petition to the US Court of Federal Claims and a copy to HHS; uploading only the HRSA copy does not file the court case. CICP uses an administrative process, generally requiring filing within one year of receiving the countermeasure and evidence of its use and medical records. Applications and letters of intent are not accepted by email or fax. Promptly verify deadlines, exceptions and evidence with VICP at 800-338-2382 or CICP at 855-266-2427. Both require formal review; a filed claim is not proof of causation. Official sources: https://www.hrsa.gov/cicp/cicp-vicp https://www.hrsa.gov/vaccine-compensation/how-to-file https://www.hrsa.gov/cicp Checked: October 4, 2026 (Pacific Time). Reference guide, not breaking news; original publication date unconfirmed. Photo: Test tubes, 2006; not vaccines, injury evidence, patient samples or an HRSA laboratory. Jeffrey M. Vinocur · CC BY 2.5 · 2006-04-21. Test tubes, 2006; not vaccines, injury evidence, patient samples or an HRSA laboratory. Licence: https://creativecommons.org/licenses/by/2.5/ Photo source: https://commons.wikimedia.org/wiki/File:Test_tubes.jpg Display-size derivative; no INL3 content edits. Jeffrey M. Vinocur · CC BY 2.5 · 2006-04-21. Test tubes, 2006; not vaccines, injury evidence, patient samples or an HRSA laboratory. Licence: https://creativecommons.org/licenses/by/2.5/ --- 來源 / Source: HRSA VICP and CICP injury compensation programs 原文與詳細資訊 / Read the original source 由 INL3 編輯帳戶整理的原創雙語摘要；此帳戶不是原媒體、業主、招聘者或醫療服務提供者。 Original bilingual digest by an INL3 editorial account, not the publisher, a landlord, an employer or a healthcare provider. 影片使用原發布者的播放器；圖片另列出處，示意圖並非新聞現場。 Videos use the original uploader's player. Image credits are separate; illustrations do not depict the event.